Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies.
Greenhawt M, Shaker M, Winders T, Bukstein DA, Davis RS, Oppenheimer J, Fleischer DM, Kim E, Chan ES, Stukus DR, Matlock D.
Greenhawt M, et al. Among authors: bukstein da.
Ann Allergy Asthma Immunol. 2020 Jul;125(1):90-96. doi: 10.1016/j.anai.2020.01.030. Epub 2020 Feb 11.
Ann Allergy Asthma Immunol. 2020.
PMID: 32057932